Loading clinical trials...
Loading clinical trials...
A Phase 3, Multicenter, Double-Blind, Placebo-Controlled, Single-Treatment Efficacy and Safety Study of MYOBLOC® (Part A) Followed by Open-Label, Multiple-Treatment With MYOBLOC® (Part B) in the Treatment of Troublesome Sialorrhea in Adult Subjects
Conditions
Interventions
MYOBLOC
PLACEBO
Locations
34
United States
Loma Linda, California, United States
Los Angeles, California, United States
National City, California, United States
Aurora, Colorado, United States
Washington D.C., District of Columbia, United States
Boca Raton, Florida, United States
Start Date
November 1, 2013
Primary Completion Date
January 1, 2016
Completion Date
January 1, 2017
Last Updated
July 13, 2021
NCT07158359
NCT06101160
NCT03747536
NCT02382198
NCT01844648
Lead Sponsor
Supernus Pharmaceuticals, Inc.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions